)
Apotea (APOTEA) investor relations material
Apotea Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q4 2025 net revenue grew 7% year-over-year to SEK 1,854.3 million, with full-year revenue reaching SEK 7,203.3 million and adjusted EBIT margin of 4.2%.
Q4 profitability was weak, with an EBIT margin of 1.3%, impacted by lower gross margin and increased depreciation from the Varberg fulfilment centre.
2025 featured major investments, including the ramp-up of the Varberg fulfilment centre and launch of a prescription hub in Årsta.
Strategic shift towards external growth, with expansion into Norway and the appointment of a Chief Growth Officer.
The Board proposes a dividend of SEK 0.60 per share for 2025, supported by a solid financial position.
Financial highlights
Q4 revenues: SEK 1,854.3 million, up 7% year-over-year; full-year revenues: SEK 7,203.3 million, up 10.1%.
Q4 gross margin: 24.8%, down from 27.0% last year, due to campaign sales and higher procurement costs.
Q4 adjusted EBIT margin: 1.3% (3.9% last year); full-year adjusted EBIT margin: 4.2% (4.4% last year).
Operating costs and depreciation increased due to Varberg investments.
Strong operating cash flow for the year, but Q4 cash flow was weaker due to automation-related payments and changes in accounts payable.
Outlook and guidance
Management targets doubling net revenue in 4–5 years and a long-term EBIT margin of 7–8%.
Short- to medium-term EBIT margin goal is 3–5%.
Focus on accelerating growth initiatives, expanding into Norway, and scaling up Varberg operations.
Expectation of significantly lower investments going forward, focusing on efficiency improvements in existing warehouses.
No specific short-term growth forecast, but management anticipates improvement as new initiatives take effect.
- TimeTickerHeadlineOpen
- 7 FebPGIL
Strong 9MFY26 growth with 13.2% higher revenue, margin gains, and upgraded credit ratings. - 7 Feb504614
Strong revenue and profit growth in Q3 FY26, led by power and steel segments. - 7 FebCHEMPLASTS
Net losses widened and revenue fell year-over-year amid regulatory and market headwinds. - 7 FebSBIN
Q3 FY26 net profit reached ₹21,028.15 crore, driven by robust income and strategic divestments. - 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights. - 6 FebKKR
Charter amendments seek to modernize governance and establish one share, one vote by 2026.
Next Apotea earnings date
Next Apotea earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)